Scientist II, Biologic Drug Substance Development at Alexion Pharmaceuticals, Inc.
Hamden, United States
Join Prog.AI to see contacts
Join Prog.AI to see contacts
Summary
👤
Senior
🎓
Top School
Matthew Wilhelm is a chemical engineer and Scientist II in Biologic Drug Substance Development with nine years of experience bridging process engineering, pilot-scale manufacturing, and advanced process modeling. He specializes in reduced-space global optimization for complex dynamical systems, blending physics-based models with machine learning surrogates and delivering open-source tools that operationalize those methods. His work spans industry and academia—from Corning process scale-up and two patents to doctoral research producing theoretical advances for MINLPs/SIPs and multiple publications. Known for translating sophisticated optimization theory into practical cost-saving solutions, he has driven multi-million-dollar impact while mentoring junior engineers and contributing reproducible software for challenging simulation-driven problems.
9 years of coding experience
13 years of employment as a software developer
Certificate in, Central European Studies Program, Certificate in, Central European Studies Program at Masarykova univerzita Právnická fakulta
Master of Science, Chemical Engineering, Master of Science, Chemical Engineering at Columbia University - Fu Foundation School of Engineering and Applied Science
Doctor of Philosophy (Ph.D.), Chemical Engineering, Doctor of Philosophy (Ph.D.), Chemical Engineering at University of Connecticut
Bachelor of Science, Applied Mathematics, Minor in Chemistry, Bachelor of Science, Applied Mathematics, Minor in Chemistry at University of North Carolina at Greensboro
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Matthew Wilhelm - Scientist II, Biologic Drug Substance Development at Alexion Pharmaceuticals, Inc.